About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1111 record(s)
Req # A-2019-001259
Adverse Reaction Report (AER). Report numbers: E2B_02591413, E2B_02591427, E2B_02591431, E2B_02596088, E2B_02596675.Organization: Health Canada
January 2020
Req # A-2019-001261
Adverse Reaction Report (AER) for Gammagard Liquid and Gammagard SD. Report numbers: 000722667, 000723660, 000723708, 000724567, 000725310.Organization: Health Canada
January 2020
Req # A-2019-001609
Adverse Reaction Report (AER). Report number: E2B_02481687.Organization: Health Canada
January 2020
Req # A-2019-001262
Adverse Reaction Report (AER) for Gammagard Liquid and Gammagard SD. Report numbers: 000725400, 000725572, 000726890, 000727785.Organization: Health Canada
January 2020
Req # A-2019-001264
Adverse Reaction Report (AER). Report numbers: 000722857, 000724367, 000725139, 000725150, 000725185.Organization: Health Canada
January 2020
Req # A-2019-001265
Adverse Reaction Report (AER) for Gammagard Liquid and Gammagard SD. Report numbers: E2B_02594625, E2B_02624862, E2B_02652261.Organization: Health Canada
January 2020
Req # A-2019-001266
Adverse Reaction Report (AER). Report numbers: 000726805, E2B_02437670, E2B_02442150, E2B_02442945, E2B_02461165.Organization: Health Canada
January 2020
Req # A-2019-001268
Adverse Reaction Report (AER). Report number: E2B_02525816.Organization: Health Canada
January 2020
Req # A-2019-001287
Adverse Reaction Report (AER). Report numbers: E2B_01905712, E2B_02250308, E2B_02110552, E2B_02304454, E2B_02158430, E2B_02196773, E2B_02202344, E2B_02342091, E2B_02196705, E2B_02259451.Organization: Health Canada
January 2020
Req # A-2019-001308
Adverse Reaction Report (AER) for Mesalamine, Mesalazin. Report numbers: E2B_02606624, E2B_02606638, E2B_0260664, E2B_02603286, E2B_02605383.Organization: Health Canada
January 2020